| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |